Semaglutide
GLP-1 / metabolic · By Preptide Pro editorial team · Last updated
Semaglutide is a glp-1 / metabolic peptide, and it has an FDA-approved product. A long-acting GLP-1 receptor agonist. Approved by the FDA for type 2 diabetes, chronic weight management and cardiovascular risk reduction.
FDA-approved (see products)Chemistry (PubChem)
| PubChem CID | 56843331 |
|---|---|
| CAS number | 910463-68-2 |
| Molecular formula | C187H291N45O59 |
| Molecular weight | 4114 g/mol |
| Other names | Semaglutide, Ozempic, Rybelsus, Wegovy, NN9535, semaglutida, semaglutidum, NN 9535 |
Is Semaglutide FDA-approved?
| Brand | Application | Status | Sponsor |
|---|---|---|---|
| OZEMPIC | NDA213051 | Prescription | NOVO |
| RYBELSUS | NDA213051 | Prescription | NOVO |
| RYBELSUS | NDA213182 | Prescription | NOVO NORDISK INC |
| OZEMPIC | NDA209637 | Prescription | NOVO |
| OZEMPIC | NDA209637 | Discontinued | NOVO |
| WEGOVY | NDA215256 | Prescription | NOVO |
| WEGOVY HD | NDA215256 | Prescription | NOVO |
| WEGOVY FLEXTOUCH | NDA215256 | Prescription | NOVO |
| WEGOVY | NDA218316 | Prescription | NOVO |
How much research is there on Semaglutide?
PubMed lists 6,013 records for “semaglutide”, of which 355 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| Food noise: A theoretical review. | Appetite | 2027 Jan 1 |
| Metabolic effects of a GLP-1 analog combined with aerobic training in ovariectomized rats. | Mol Cell Endocrinol | 2027 Jan |
| Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study. | Libyan J Med | 2026 Dec 31 |
| Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide. | Int J Qual Stud Health Well-being | 2026 Dec 31 |
| Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/δ-opioid receptor pathway. | Neuropharmacology | 2026 Dec 15 |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.